These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25315227)

  • 1. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors.
    Ambruso DR
    Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients.
    Mayor S
    BMJ; 2013 Oct; 347():f6197. PubMed ID: 24126958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controversy over the use of hydroxyethyl starch solutions. Is the use of low molecular weight hydroxyethyl starch contraindicated?].
    Sánchez CA; Asuero MS;
    Rev Esp Anestesiol Reanim; 2014; 61(6):299-303. PubMed ID: 24838121
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis.
    Lee JH; Leitman SF; Klein HG
    Blood; 1995 Dec; 86(12):4662-6. PubMed ID: 8541559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor reaction to hydroxyethyl starch during granulocytapheresis.
    Dutcher JP; Aisner J; Hogge DE; Schiffer CA
    Transfusion; 1984; 24(1):66-7. PubMed ID: 6198788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis.
    Lee JH; Cullis H; Leitman SF; Klein HG
    J Clin Apher; 1995; 10(4):198-202. PubMed ID: 8770713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.
    Bryant BJ; Yau YY; Byrne PJ; Stroncek DF; Leitman SF
    Transfusion; 2010 Jun; 50(6):1203-9. PubMed ID: 20113453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytapheresis with modified fluid gelatin versus high-molecular-weight hydroxyethyl starch: a matched-pair analysis.
    Dullinger K; Pamler I; Brosig A; Mohrez M; Hähnel V; Offner R; Dormann F; Becke C; Holler E; Ahrens N
    Transfusion; 2017 Feb; 57(2):397-403. PubMed ID: 27859322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of hydroxyethyl starch.
    Jungheinrich C; Neff TA
    Clin Pharmacokinet; 2005; 44(7):681-99. PubMed ID: 15966753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eighteen years experience of granulocyte donations-acceptable donor safety?
    Axdorph Nygell U; Sollén-Nilsson A; Lundahl J
    J Clin Apher; 2015 Oct; 30(5):265-72. PubMed ID: 25546372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethylstarch sedimentation by gravity ex vivo for red cell reduction of granulocyte apheresis components.
    Adkins D; Johnston M; Walsh J; Spitzer G; Goodnough T
    J Clin Apher; 1998; 13(2):56-61. PubMed ID: 9704606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydroxyethyl starch in critically ill patients.
    Brunkhorst FM; Schortgen F
    Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity.
    Pagano MB; Harmon C; Cooling L; Connelly-Smith L; Mann SA; Pham HP; Marques MB; Schlueter AJ; Case R; King KE; Cataife G; Wu Y; Wong EC; Winters JL
    Transfusion; 2016 Nov; 56(11):2848-2856. PubMed ID: 27600855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive granulocyte donation on donors and yields.
    Strauss RG; Goeken JA; Eckermann I; McEntegart CM; Hulse JD
    Transfusion; 1986; 26(5):441-5. PubMed ID: 2429411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of hydroxyethyl starch-containing fluids.
    Aubron C; Bellomo R
    Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of granulocyte donations.
    Huestis DW
    Prog Clin Biol Res; 1982; 88():101-14. PubMed ID: 6179099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
    Wiedermann CJ
    Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy.
    Ikemoto J; Yoshihara S; Fujioka T; Ohtsuka Y; Fujita N; Kokubunji A; Okamoto N; Ono J; Taniguchi K; Kaida K; Ikegame K; Okada M; Tanizawa T; Ogawa H; Kai S
    Transfusion; 2012 Dec; 52(12):2646-52. PubMed ID: 22519863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.